Extracorporeal photopheresis as a curative treatment strategy in non epidermotropic t-cell lymphoma and large granular lymphocyte leukemia

Annals of Oncology

Volumn 23, Issue 9, 2012, Pages 2386-2390

  Garban, F ^a   Carras, S ^a   Drillat, P ^b   Jacob, M C ^a,c   Fabre, B ^a   Callanan, M ^a,c   Courby, S ^a   Makowski, C ^b   Cahn, J Y ^a,d   Gressin, R ^a,c  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b Grenoble Site   (France)

^c INSERM   (France)

^d LABORATOIRE TIMC IMAG   (France)

Author keywords

LGL; Peripheral T cell lymphoma; Photopheresis; PTCL

Indexed keywords

ASPARAGINASE; BLEOMYCIN; CARMUSTINE; CHLORAMBUCIL; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; INTERFERON; LOMUSTINE; MELPHALAN; METHOTREXATE; PREDNISOLONE; TENIPOSIDE; VINCRISTINE; VINDESINE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER RELAPSE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG EFFICACY; FLOW CYTOMETRY; HUMAN; LARGE GRANULAR LYMPHOCYTE LEUKEMIA; LEUKAPHERESIS; MAINTENANCE THERAPY; OUTCOME ASSESSMENT; PERIPHERAL T CELL LYMPHOMA; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; PUVA; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT PLANNING; TREATMENT RESPONSE;

ADULT; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; LEUKEMIA, LARGE GRANULAR LYMPHOCYTIC; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; PHOTOPHERESIS; TREATMENT OUTCOME;

EID: 84865550802     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mds014     Document Type: Article

References (21)

1. Edelson R, Berger C, Gasparro F et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. N Engl J Med 1987; 316: 297-303.
2. Trautinger F, Knobler R, Willemze R et al. EORTC consensus recommendations for the treatment of mycosis fungoides/Sezary syndrome. Eur J Cancer 2006; 42: 1014-1030.
3. Knobler R, Barr ML, Couriel DR et al. Extracorporeal photopheresis: past, present, and future. J Am Acad Dermatol 2009; 61: 652-665.
4. Garban F, Drillat P, Makowski C et al. Extracorporeal chemophototherapy for the treatment of graft-versus-host disease: hematologic consequences of short-term, intensive courses. Haematologica 2005; 90: 1096-1101.
5. Berger C, Hoffmann K, Vasquez JG et al. Rapid generation of maturationally synchronized human dendritic cells: contribution to the clinical efficacy of extracorporeal photochemotherapy. Blood 2010; 116: 4838-4847.
6. Savage KJ. Prognosis and primary therapy in peripheral T-cell lymphomas. Hematology Am Soc Hematol Educ Program 2008; 2008: 280-288.
7. Simon A, Peoch M, Casassus P et al. Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95. Br J Haematol 2010; 151: 159-166.
8. Lamy T, Loughran TP, Jr. How we treat LGL leukemia. Blood 2010; 117: 2764-2774.
9. Swerdlow S, Campo E, Harris NL et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press 2008.
10. Salameire D, Le Bris Y, Fabre B et al. Efficient characterization of the TCR repertoire in lymph nodes by flow cytometry. Cytometry A 2009; 75: 743-751.
11. Beck RC, Stahl S, O'Keefe CL et al. Detection of mature T-cell leukemias by flow cytometry using anti-T-cell receptor V beta antibodies. Am J Clin Pathol 2003; 120: 785-794.
12. Andreu G, Leon A, Heshmati F et al. Extracorporeal photochemotherapy: evaluation of two techniques and use in connective tissue disorders. Transfus Sci 1994; 15: 443-454.
13. Jacob MC, Manches O, Drillat P et al. Quality control for the validation of extracorporeal photopheresis process using the Vilbert-Lourmat UV-A irradiation's system. Transfus Apher Sci 2003; 28: 63-70.
14. Cheson BD, Horning SJ, Coiffier B et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999; 17: 1244.
15. Marks DI, Rockman SP, Oziemski MA, Fox RM. Mechanisms of lymphocytotoxicity induced by extracorporeal photochemotherapy for cutaneous T cell lymphoma. J Clin Invest 1990; 86: 2080-2085.
16. Rook AH, Suchin KR, Kao DM et al. Photopheresis: clinical applications and mechanism of action. J Investig Dermatol Symp Proc 1999; 4: 85-90.
17. Hannani D, Merlin E, Gabert F et al. Photochemotherapy induces a faster apoptosis of alloreactive activated T cells than of nonalloreactive resting T cells in graft versus host disease. Transplantation 2010; 90: 1232-1238.
18. Setterblad N, Garban F, Weigl R et al. Extracorporeal photophoresis increases sensitivity of monocytes from patients with graft-versus-host disease to HLA-DRmediated cell death. Transfusion 2008; 48: 169-177.
19. O'Connor OA, Pro B, Pinter-Brown L et al. Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study. J Clin Oncol 2011; 29: 1182-1189.
20. Piekarz RL, Frye R, Prince HM et al. Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma. Blood 2011; 117: 5827-5834.
21. Damaj G, Gressin R, Bouabdallah K et al. Preliminary results from an open label multi-center, phase II study of bendamustine in relapsed or refractory T-cell lymphoma from the French GOELAMS group: the Bently trial. Ann Oncol 2011; 22(Suppl 4)126.